Investor Presentaiton

Polo-like kinase-1 identified as a therapeutic target in RDEB CSCC 17 Oncogene. 2011 30(46):4666-77. PMID: 21602893 PMCID: PMC3219832 Isolate primary cells from cSCC Gene expression analysis in vitro Tumour cells scored through genetic alteration, either SNP mapping or cytogenetics Integrative analysis comparing clinical expression data siRNA screen In vitro target validation In vivo validation 0 ONCONOVA THERAPEUTICS

View entire presentation